Results 171 to 180 of about 97,001 (288)

The Effect of Sugammadex on Prothrombin and Activated Partial Thromboplastin Time. [PDF]

Cureus, 2021
Samara E, Stamatiou K, Balanika M, Tzimas P.   +3 more
europepmc   +1 more source

A 60 Year Old Man with Activated Partial Thromboplastin Time without Hemorrhagic Tendency

, 2008
Fumio Maruyama, Nobuhiko Emi
openalex   +2 more sources

Anticoagulation in syncardia total artificial heart recipients: anti-factor Xa or activated partial thromboplastin time? [PDF]

Interact Cardiovasc Thorac Surg, 2022
Monteagudo-Vela M, Bowles C, Raj B, Robinson D, Simon A.   +4 more
europepmc   +1 more source

MOLECULAR ASPECT CORRELATION BETWEEN GLYCATED HEMOGLOBIN (HBA1C), PROTHROMBIN TIME (PT) AND ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT) ON TYPE 2 DIABETES MELLITUS (T2DM) (Aspek molekuler Hubungan Kadar Hemoglobin Terglikasi (HbA1c), Prothrombin Time (PT) dan Activated Partial Thromboplastin Time (APTT) di Diabetes Melitus Tipe 2)

, 2018
Indranila Ks
openalex   +2 more sources

Unsuitability of evacuated tubes for monitoring heparin therapy by activated partial thromboplastin time. [PDF]

, 1981
A. du P. Heyns, Daniel Berg, Pht Kleynhans, P W du Toit   +3 more
openalex   +1 more source

A Comparison of Activated Partial Thromboplastin Time and Activated Coagulation Time for Anticoagulation Monitoring during Extracorporeal Membrane Oxygenation Therapy. [PDF]

Hamostaseologie, 2023
Liu Y, Yuan Z, Han X, Song K, Xing J.
europepmc   +1 more source

A prolonged activated partial thromboplastin time indicates poor short-term prognosis in patients with hepatic encephalopathy: insights from the MIMIC database. [PDF]

Front Med (Lausanne)
Zhan L, Yang Y, Nie B, Kou Y, Du S, Tian Y, Huang Y, Ye R, Huang Z, Luo B, Ge L, Ye S.   +11 more
europepmc   +1 more source

Activated Partial Thromboplastin Time and Anti-IIa Monitoring in Argatroban Anticoagulation in COVID-19 Patients on Venovenous Extracorporeal Membrane Oxygenation. [PDF]

Clin Appl Thromb Hemost
Burša F, Frelich M, Sklienka P, Němcová S, Kučerová Z, Jor O, Romanová T, Kondé A, Janošek J, Sagan J, Máca J.   +10 more
europepmc   +1 more source

Anti-Factor-Xa and Activated Partial Thromboplastin Time Concordance and Outcomes in Adults Undergoing Extracorporeal Membrane Oxygenation: A Secondary Analysis of the Pilot Low-Dose Heparin in Critically Ill Patients Undergoing Extracorporeal Membrane Oxygenation Randomized Trial. [PDF]

Crit Care Explor, 2023
Aubron C, Chapalain X, Bailey M, Board J, Buhr H, Cartwright B, Dennis M, Hodgson C, Forrest P, McIlroy D, Murphy D, Murray L, Pellegrino V, Pilcher D, Sheldrake J, Tran H, Vallance S, Cooper DJ, McQuilten Z.   +18 more
europepmc   +1 more source

Retrospective cohort study comparing activated partial thromboplastin time versus anti‐factor Xa activity nomograms for therapeutic unfractionated heparin monitoring in pediatrics

Journal of Thrombosis and Haemostasis, 2015
M. Trucco, Christoph U. Lehmann, N. Mollenkopf, M. Streiff, C. Takemoto   +4 more
semanticscholar   +1 more source